Showing results (11-20 of 25) with videos related to
Sort By:
Pageof 3
Psoriasis (Auckland, N.Z.)|February 2, 2018
Clinical utility of ixekizumab in the treatment of moderate-to-severe plaque psoriasisSahil Sekhon, Caleb Jeon, Mio Nakamura, et al.Psoriasis (Auckland, N.Z.)|August 22, 2017
The metabolomics of psoriatic diseaseDi Yan, Ladan Afifi, Caleb Jeon, et al.Dermatology and Therapy|June 23, 2017
Guselkumab for the Treatment of Psoriasis: A Review of Phase III TrialsMio Nakamura, Katherine Lee, Caleb Jeon, et al.Journal of the American Academy of Dermatology|December 31, 2017
Diagnosis and management of peristomal pyoderma gangrenosum: A systematic reviewLadan Afifi, Isabelle M Sanchez, Matthew M Wallace, et al.The Journal of Dermatological Treatment|January 4, 2017
Dietary modifications in atopic dermatitis: patient-reported outcomesAdi Nosrati, Ladan Afifi, Melissa J Danesh, et al.The Journal of Dermatological Treatment|August 18, 2017
Review of the mechanism of action of coal tar in psoriasisSahil Sekhon, Caleb Jeon, Mio Nakamura, et al.Molecular and Clinical Oncology|April 10, 2024
Challenges in utilizing ALK expression to distinguish primary cutaneous from systemic anaplastic large cell lymphomaLaura Gleason, Ladan Afifi, Lauren Banner, et al.Lasers in Surgery and Medicine|April 27, 2016
Low-level laser therapy as a treatment for androgenetic alopeciaLadan Afifi, Eric L Maranda, Mina Zarei, et al.Current Pain and Headache Reports|November 3, 2017
Pain, Psychological Comorbidities, Disability, and Impaired Quality of Life in Hidradenitis Suppurativa [corrected]Zarine S Patel, Lauren K Hoffman, Dawn C Buse, et al.Current Pain and Headache Reports|November 20, 2017
Correction to: Pain, Psychological Comorbidities, Disability, and Impaired Quality of Life in Hidradenitis SuppurativaZarine S Patel, Lauren K Hoffman, Dawn C Buse, et al.Pageof 3